Clinical Trial Details
| Trial ID: | L0495 |
| Source ID: | NCT00338468 |
| Associated Drug: | Epoetin Alfa |
| Title: | A Study to Assess Disability in Anemic Elderly Patients With Kidney Disease Receiving PROCRIT (Epoetin Alfa) |
| Acronym: | |
| Status: | TERMINATED |
| Study Results: | NO |
| Results: | |
| Conditions: | Anemia|Kidney Diseases |
| Interventions: | DRUG: epoetin alfa |
| Outcome Measures: | Primary: Change in physical function score as measured by the Six Minute Walk Test (6MWT) and Short Physical Performance (SPP) Summary Score compared from Baseline to Week 5, Week 9, Week 13, Week 17/ Early Withdrawal and Week 20/Follow-up. | Secondary: Proportion of patients who achieve the target hemoglobin levels of > 13.0 g/dL and < =14.0 g/dL (independent of transfusion within 1 month of assessment) compared from Baseline to Week 5, Week 9, Week 13, Week 17/ Early Withdrawal and Week 20/Follow-up. |
| Sponsor/Collaborators: | Sponsor: Ortho Biotech Products, L.P. |
| Gender: | ALL |
| Age: | OLDER_ADULT |
| Phases: | PHASE4 |
| Enrollment: | 13 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2003-11 |
| Completion Date: | 2005-09 |
| Results First Posted: | |
| Last Update Posted: | 2011-05-19 |
| Locations: | |
| URL: | https://clinicaltrials.gov/show/NCT00338468 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|